Results 91 to 100 of about 2,864 (172)

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. [PDF]

Emerg Infect Dis
Seung KJ, Asfaw M, Kunda M, Maama-Maime LB, Makaka J, Mofolo M, Mpinda S, Ndayizigiye M, Omar SV, Prasad P, Rupasinghe P, Yarbrough C, Oyewusi L.   +12 more
europepmc   +1 more source

Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant <i>Mycobacterium tuberculosis</i> from a Single Institute in South Korea. [PDF]

Pathogens
Choi HW, Kang YR, Son ES, Choi K, Cho M, Kim YJ, Lee SA, Lee JY, Kim JH, Kang SJ, Kee SJ, Lee JS, Lee HJ.   +12 more
europepmc   +1 more source

Successful treatment of pre-extensively drug-resistant tuberculous meningoencephalomyelitis in pregnancy with a bedaquiline and delamanid-based regimen: a case report. [PDF]

BMC Infect Dis
Nie Q, Liu Y, Xiao F, Zhou Y, Fu T, Zheng L, Huang D, Tang Q, Liu T, Tao L.   +9 more
europepmc   +1 more source

Wild-type MIC distribution and evaluation of epidemiological cut-offs of second-line TB-drugs in susceptible and MDR-TB clinical isolates from Chennai, India. [PDF]

Front Microbiol
Dusthackeer A, Balasubramanian M, Rajadas SE, Nirmal CR, Elango P, Thiruvengadam K, Saadhali SA, Shanmugam S.   +7 more
europepmc   +1 more source

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era. [PDF]

Clin Infect Dis
Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, Fox GJ, Harrington M, Chaisson RE, Hesseling AC.   +9 more
europepmc   +1 more source

A drug-resistant TB cluster in a refugee family with Mendelian susceptibility to mycobacterial disease (MSDM). [PDF]

IJTLD Open
Boktor HAZ, Monedero-Recuero I, Al Shatnawi A, Halaseh H, Nejm MA, Satyanarayana S, Wilson N, Dent R, Maaia I, Okkeh K.   +9 more
europepmc   +1 more source

<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Antimicrob Agents Chemother
Rupasinghe P, Ismail N, Mulders W, Warren RM, Joseph L, Ngcamu D, Gwala T, Omar SV, Vereecken J, de Jong BC, Rigouts L, Borroni E, Cirillo DM, Schön T, Miotto P, Köser CU.   +15 more
europepmc   +1 more source

Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR.   +4 more
europepmc   +1 more source

Therapy-induced cardiotoxicity in drug-resistant tuberculosis patients: A systematic review and meta-analysis. [PDF]

Glob Cardiol Sci Pract
Liastuti LD, Kohar K, Lestari HM, Pritazahra A.   +3 more
europepmc   +1 more source

Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database. [PDF]

BMJ Open
Zhao L, Zeng L, Qian Y, Zhao W, Xie R.
europepmc   +1 more source